Literature DB >> 16614546

Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia.

Katherine E Burdick1, Joseph F Goldberg, Martin Harrow, Robert N Faull, Anil K Malhotra.   

Abstract

Linkage and association studies have paid increasing attention to neurocognition as a putative endophenotype. However, there exists little documentation of its trait stability in schizophrenia or bipolar disorder. Our aim was to determine the longitudinal stability of neurocognitive performance in bipolar versus schizophrenia probands. We administered a neurocognitive battery at two time points, approximately 5 years apart, in 16 schizophrenia and 16 bipolar disorder age-matched subjects. There were no significant changes over time on variables including education, estimated IQ, depression, psychosis, global functioning, or medication status. Schizophrenia subjects showed significant deterioration in one measure of executive functioning but no significant changes in seven of eight other domains. Bipolar patients showed stability over time in attentional measures but greater variability in other domains. These preliminary findings suggest that neurocognitive domains appear longitudinally stable across broad domains in schizophrenia. In contrast, stable functioning may be more limited to attentional domains in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614546     DOI: 10.1097/01.nmd.0000207360.70337.7e

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  44 in total

1.  General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance.

Authors:  Alex Fornito; Jong Yoon; Andrew Zalesky; Edward T Bullmore; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

2.  The texture of the real: experimentation and experience in schizophrenia.

Authors:  Elizabeth Bromley
Journal:  Cult Med Psychiatry       Date:  2012-03

3.  Cognitive impairments in major depression and bipolar disorders.

Authors:  Philip D Harvey
Journal:  Psychiatry (Edgmont)       Date:  2007-01

4.  Neurocognition in schizophrenia: a 20-year multi-follow-up of the course of processing speed and stored knowledge.

Authors:  Aaron Bonner-Jackson; Linda S Grossman; Martin Harrow; Cherise Rosen
Journal:  Compr Psychiatry       Date:  2010-03-29       Impact factor: 3.735

5.  A video ethnography approach for linking naturalistic behaviors to research constructs of neurocognition in schizophrenia.

Authors:  Elizabeth Bromley; Gail Fox Adams; John S Brekke
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

6.  Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Joseph F Goldberg
Journal:  J Abnorm Psychol       Date:  2012-05-28

7.  Attention/processing speed prospectively predicts social impairment 18 years later in mood disorders.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Robert N Faull
Journal:  J Nerv Ment Dis       Date:  2013-09       Impact factor: 2.254

8.  Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder.

Authors:  Michael S McCloskey; Antonia S New; Larry J Siever; Marianne Goodman; Harold W Koenigsberg; Janine D Flory; Emil F Coccaro
Journal:  J Psychiatr Res       Date:  2009-02-18       Impact factor: 4.791

9.  DTNBP1 genotype influences cognitive decline in schizophrenia.

Authors:  Katherine E Burdick; Terry E Goldberg; Birgit Funke; John A Bates; Todd Lencz; Raju Kucherlapati; Anil K Malhotra
Journal:  Schizophr Res       Date:  2006-10-30       Impact factor: 4.939

10.  Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.

Authors:  Erin A Hazlett; Ethan G Rothstein; Rui Ferreira; Jeremy M Silverman; Larry J Siever; Ann Olincy
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.